UK Cell Therapy Market Size & Outlook, 2023-2030
UK cell therapy market, 2018-2030 (US$M)
Related Markets
UK cell therapy market highlights
- The UK cell therapy market generated a revenue of USD 410.1 million in 2023 and is expected to reach USD 2,089.5 million by 2030.
- The UK market is expected to grow at a CAGR of 26.2% from 2024 to 2030.
- In terms of segment, autologous therapies was the largest revenue generating therapy type in 2023.
- Allogeneic Therapies is the most lucrative therapy type segment registering the fastest growth during the forecast period.
Cell therapy market data book summary
| Market revenue in 2023 | USD 410.1 million |
| Market revenue in 2030 | USD 2,089.5 million |
| Growth rate | 26.2% (CAGR from 2023 to 2030) |
| Largest segment | Autologous therapies |
| Fastest growing segment | Allogeneic Therapies |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Allogeneic Therapies, Autologous Therapies |
| Key market players worldwide | Novartis AG ADR, Gilead Sciences Inc, Bristol-Myers Squibb Co, Johnson & Johnson, JCR Pharmaceuticals Co Ltd, JW (Cayman) Therapeutics Co Ltd Ordinary Shares, Atara Biotherapeutics Inc, Medipost, Beiersdorf AG, Nkarta Inc Ordinary Shares |
Other key industry trends
- In terms of revenue, UK accounted for 8.7% of the global cell therapy market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany cell therapy market is projected to lead the regional market in terms of revenue in 2030.
- Switzerland is the fastest growing regional market in Europe and is projected to reach USD 341.8 million by 2030.
Key Regions: U.S. , Japan , Canada , Germany , Switzerland
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Therapy Market Scope
Cell Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK cell therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell therapy market will help companies and investors design strategic landscapes.
Autologous therapies was the largest segment with a revenue share of 99.63% in 2023. Horizon Databook has segmented the UK cell therapy market based on allogeneic therapies, autologous therapies covering the revenue growth of each sub-segment from 2018 to 2030.
The UK cell therapy market is expected to grow significantly owing to the increasing expansions of manufacturing capacities of cell therapies and the rising focus of industry participants on cell therapies. The industry participants operating in the UK are boosting their cell therapy manufacturing abilities.
For instance, in March 2023, the National Health Service Blood and Transplant (NHSBT) launched a new Clinical Biotechnology Centre (CBC) to increase the country’s capacity to manufacture and develop cell & gene therapies. Such expansions are anticipated to boost the competition in the country in the coming years.
Furthermore, in June 2022, the Cell and Gene Therapy Catapult (CGT Catapult) introduced a new consortium in the country to drive innovation in the manufacturing of personalized cell therapies. Such developments are anticipated to propel the cell therapy market.
Reasons to subscribe to UK cell therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK cell therapy market databook
-
Our clientele includes a mix of cell therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK cell therapy market , including forecasts for subscribers. This country databook contains high-level insights into UK cell therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK cell therapy market size, by therapy type, 2018-2030 (US$M)
UK Cell Therapy Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
